N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 2957-2966

  De Freitas Junior, Julio Cesar Madureira ^a,b   Bastos, Lilian Golçalves ^a   Freire Neto, Carlos Alberto ^a   Rocher, Bárbara Du ^a   Abdelhay, Eliana Saul Furquim Werneck ^a   Morgado Díaz, José Andrés ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

colorectal cancer; N glycosylation; radiosensitivity; Tunicamycin

Indexed keywords

CISPLATIN; IRINOTECAN; SWAINSONINE; TUNICAMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL ANCHORAGE; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW DRUG DOSE; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION;

BLOTTING, WESTERN; CACO-2 CELLS; CAMPTOTHECIN; CELL MOVEMENT; CELL SURVIVAL; CISPLATIN; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; HCT116 CELLS; HT29 CELLS; HUMANS; POLYSACCHARIDES; SWAINSONINE; TUNICAMYCIN;

EID: 84863671035     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24173     Document Type: Article

References (47)

1. Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Göke B, Dambacher J,. 2006. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97: 709-723.
2. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A,. 1988. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res 48: 1936-1942.
3. Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL,. 2007. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res 7: 4013-4020.
4. Clarke R, Cook KL, Hu R, Facey CO, Tavassoly I, Schwartz JL, Baumann WT, Tyson JJ, Xuan J, Wang Y, Wärri A, Shajahan AN,. 2012. Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res 72: 1321-1331.
5. Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS,. 2008. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res 68: 3803-3809.
6. Contessa JN, Mahaveer SB, Freeze HH, Ross BD, Rehemtulla A, Lawrence TS,. 2010. Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res 16: 3205-3214.
7. de Albuquerque Garcia Redondo P, Nakamura CV, de Souza W, Morgado-Diaz JA,. 2004. Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem 52: 629-640.
8. de Araújo WM, Vidal FC, de Souza WF, de Freitas Junior JC, de Souza W, Morgado-Diaz JA,. 2010. PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells. J Cancer Res Clin Oncol 136: 1773-1782.
9. de Freitas Junior JC, Du Rocher B, de Souza WF, de Araújo WM, Abdelhay ES, Morgado-Díaz JA,. 2011. Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells. Cancer Chemother Pharmacol 68: 227-238.
10. Elbein AD,. 1987. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chain. Annu Rev Biochem 56: 497-534.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, Parkin D,. 2010. D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; Year. Available at: http://globocan.iarc.fr.
12. Freyer G, Bossard N, Romestaing P, Mornex F, Chapet O, Trillet-Lenoir V, Gérard JP,. 2001. Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 phase I trial. J Clin Oncol 19: 2433-2438.
13. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, Barbet N, Atlan D, Adeleine P, Freyer G,. 2003. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R 0-04 phase II trial. J Clin Oncol 21: 1119-1124.
14. Gerber-Lemaire S, Juillerat-Jeanneret L,. 2010. Studies toward new anti-cancer strategies based on alpha-mannosidase inhibition. Chimia (Aarau) 64: 634-639.
15. Glynne-Jones R, Kronfli M,. 2011. Locally advanced rectal cancer: A comparison of management strategies. Drugs 71: 1153-1177.
16. Goodwin RA, Asmis TR,. 2009. Overview of systemic therapy for colorectal cancer. Clin Colon Rectal Surg 22: 251-256.
17. Goss PE, Reid CL, Bailey D, Dennis JW,. 1997. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advances malignancies. Clin Cancer Res 3: 1077-1086.
18. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW,. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6: 306-312.
19. Hamaguchi J, Nakagawa H, Takahashi M, Kudo T, Kamiyama N, Sun B, Oshima T, Sato Y, Deguchi K, Todo S,. 2007. Nishimura, swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines. Mol Cancer 6: 58.
20. Hiss DC, Gabriels GA, Folb PI,. 2007. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int 7: 5.
21. Iijima J, Zhao Y, Isaji T, Kameyama A, Nakaya S, Wang X, Ihara H, Cheng X, Nakagawa T, Miyoshi E, Kondo A, Narimatsu H, Taniguchi N, Gu J,. 2006. Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. J Biol Chem 281: 13038-13046.
22. Instituto Nacional de Câncer. 2011. Incidência de câncer no Brasil, Instituto Nacional de Câncer Estimativa 2012, Rio de Janeiro.
23. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. 2011. Global cancer statistics. Ca Cancer J Clin 61: 69-90.
24. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH,. 2002. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54: 403-408.
25. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR,. 2006. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 26: 3181-3193.
26. Lau K, Dennis JW,. 2008. N-glycans in cancer progression. Glycobiology 18: 750-760.
27. Leve F, Morgado-Díaz JA,. 2012. Rho GTPase signaling in the development of colorectal cancer. J Cell Biochem (in press). DOI: 10.1002/jcb.24153
28. Leve F, de Souza W, Morgado-Díaz JA,. 2008. Across-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epitelial cancer cells. J Pharmacol Exp Ther 327: 777-788.
29. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL,. 2005. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4: 21.
30. Ling YH, Li T, Perez-Soler R, Haigentz M Jr., 2009. Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib. Cancer Chemother Pharmacol 64: 539-548.
31. Loo T, Clarke D,. 1999. The human multidrugresistance P-glycoproteinis inactive when its maturation is inhibited: Potential for a role in cancer chemotherapy. FASEB J 13: 1724-1732.
32. Maeder T,. 2002. Sweet medicines. Sci Am 287: 40-47.
33. Mahoney WC, Duksin D,. 1980. Separation of tunicamycin homologues by reversed-phase high-performance liquid chromatography. J Chromatogr Sci 198: 506-510.
34. Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G,. 2003. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55: 132-137.
35. Minsky BD, Cohen AM, Enker WE, Saltz L, Guillem JG, Paty PB, Kelsen DP, Kemeny N, Ilson D, Bass J, Conti J,. 1997. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37: 289-295.
36. Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S, Honda H, Takemura F, Taniguchi N, Imaoka S,. 2000. Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 6: 1772-1777.
37. Nakata B, Sowa M, Tsuji A, Kamano T, Sasaki K, Fukunaga Y, Takahashi M, Tsujitani S, Mikami Y, Mitachi Y, Nishimura S, Araki H, Yamamitsu S, Hirakawa K, Tominaga S, Shirasaka T, Inokuchi K,. 2007. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study. J Exp Clin Cancer Res 26: 51-60.
38. Nita-Lazar M, Rebustini I, Walker J, Kukuruzinska MA,. 2010. Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res 316: 1871-1884.
39. Noda I, Fujieda S, Seki M, Tanaka M, Sunaga H, Ohtsubo T, Tsuzuki H, Fan GK, Saito H,. 1999. Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells. Int J Cancer 80: 279-284.
40. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA,. 1994. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502-507.
41. Pinho SS, Reis CA, Paredes J, MagalhÃes AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gärtner F, Seruca F,. 2009. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 18: 2599-2608.
42. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson tm, Morrison SJ,. 2008. Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
43. Sun JY, Zhu MZ, Wang SW, Miao S, Xie YH, Wang JB,. 2007. Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine. Phytomedicine 14: 353-359.
44. Smith MI, Deshmukh M,. 2007. Endoplasmic reticulum stress-induced apoptosis requires bax for commitment and Apaf-1 for execution in primary neurons. Cell Death Differ 14: 1011-1019.
45. Tanaka MN, Diaz BL, de Souza W, Morgado-Díaz JA,. 2008. Prostaglandin E2-EPI and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells. BMC Cell Biol 9: 63.
46. Vagin O, Tokhtaeva E, Iskandar Y, Eugenia S, Sachs G,. 2008. Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia. J Biol Chem 283: 2192-2202.
47. Winder T, Lenz HJ,. 2010. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology 138: 2163-2176.